Cargando…

MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families

BACKGROUND: Heritable factors are evidently involved in prostate cancer (PrCa) carcinogenesis, but currently, genetic markers are not routinely used in screening or diagnostics of the disease. More precise information is needed for making treatment decisions to distinguish aggressive cases from indo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fischer, Daniel, Wahlfors, Tiina, Mattila, Henna, Oja, Hannu, Tammela, Teuvo L. J., Schleutker, Johanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447459/ https://www.ncbi.nlm.nih.gov/pubmed/26020509 http://dx.doi.org/10.1371/journal.pone.0127427

Ejemplares similares

NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene
por: Mattila, Henna, et al.
Publicado: (2011)

PALB2 variants in hereditary and unselected Finnish Prostate cancer cases
por: Pakkanen, Sanna, et al.
Publicado: (2009)

Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer
por: Rantapero, Tommi, et al.
Publicado: (2020)

Assessing Interactions of Two Loci (rs4242382 and rs10486567) in Familial Prostate Cancer: Statistical Evaluation of Epistasis
por: Chen, Li-Sheng, et al.
Publicado: (2014)

Contribution of ARLTS1 Cys148Arg (T442C) Variant with Prostate Cancer Risk and ARLTS1 Function in Prostate Cancer Cells
por: Siltanen, Sanna, et al.
Publicado: (2011)

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer
por: Sjöblom, Liisa, et al.
Publicado: (2016)

Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease
por: Sipeky, Csilla, et al.
Publicado: (2021)

Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer
por: Kaapu, Kalle J, et al.
Publicado: (2016)

ARLTS1 and Prostate Cancer Risk - Analysis of Expression and Regulation
por: Siltanen, Sanna, et al.
Publicado: (2013)

Antihypertensive drug use and prostate cancer-specific mortality in Finnish men
por: Siltari, Aino, et al.
Publicado: (2020)

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC
por: Pashayan, Nora, et al.
Publicado: (2015)

Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer
por: Kinnunen, Pete T. T., et al.
Publicado: (2017)

Prostate cancer risk prediction using a polygenic risk score
por: Sipeky, Csilla, et al.
Publicado: (2020)

Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial
por: Veitonmäki, Thea, et al.
Publicado: (2016)

Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer
por: Murtola, Teemu J., et al.
Publicado: (2018)

Prostate cancer incidence in men with prostate‐specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer
por: Ola, Idris Olasunmbo, et al.
Publicado: (2022)

Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer
por: Talala, Kirsi, et al.
Publicado: (2020)

Anti-epileptic drugs and prostate cancer-specific mortality compared to non-users of anti-epileptic drugs in the Finnish Randomized Study of Screening for Prostate Cancer
por: Salminen, Jukka K., et al.
Publicado: (2022)

Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients
por: Pelttari, Liisa M, et al.
Publicado: (2012)

Where have all the GPs gone – where will they go? Study of Finnish GPs
por: Sumanen, Markku, et al.
Publicado: (2012)

Factors important in the choice of a medical career: a Finnish national study
por: Heikkilä, Teppo J., et al.
Publicado: (2015)

Copy Number Variation Analysis in Familial BRCA1/2-Negative Finnish Breast and Ovarian Cancer
por: Kuusisto, Kirsi M., et al.
Publicado: (2013)

Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men
por: Kaapu, Kalle J., et al.
Publicado: (2018)

The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth
por: Murtola, Teemu J., et al.
Publicado: (2012)

The landscape of somatic mutations in lymphoblastoid cell lines
por: Caballero, Madison, et al.
Publicado: (2023)

The landscape of somatic mutations in lymphoblastoid cell lines
por: Caballero, Madison, et al.
Publicado: (2023)

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial
por: Veitonmäki, T, et al.
Publicado: (2014)

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial
por: Määttänen, L, et al.
Publicado: (2007)

Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
por: Murtola, T J, et al.
Publicado: (2009)

False-positive screening results in the Finnish prostate cancer screening trial
por: Kilpeläinen, T P, et al.
Publicado: (2010)

Determinants of sickness absence rate among Finnish municipal employees
por: Vuorio, Tiina, et al.
Publicado: (2019)

Psychological recovery and well-being of spouses of patients with prostate cancer 5 years after primary treatment in Finland: a follow-up survey
por: Lehto, Ulla-Sisko, et al.
Publicado: (2023)

Instability at Short Tandem Repeats in Lymphoblastoid Cell Lines
por: Lee, Jae-Eun, et al.
Publicado: (2013)

Limitations of lymphoblastoid cell lines for functional analysis of SNPs
por: Pathak, Hansi, et al.
Publicado: (2017)

European randomized study of prostate cancer screening: first-year results of the Finnish trial
por: Määttänen, L, et al.
Publicado: (1999)

Proceedings: Cultured lymphoblastoid lines as a model for leukaemia/lymphoma.
por: Steel, C. M.
Publicado: (1975)

The ultrastructure of lymphoblastoid cell lines from Marek's disease lymphomata.
por: Frazier, J. A., et al.
Publicado: (1975)

Growth properties and alloantigenic expression of murine lymphoblastoid cell lines
Publicado: (1975)

The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
por: Skalsky, Rebecca L., et al.
Publicado: (2012)

Genetic and genomic stability across lymphoblastoid cell line expansions
por: Scheinfeldt, Laura B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4g4156opt7pml1alv5q3br9rnp